Maybe I can start.
There are essentially two questions there. One is with respect to labelling and the other is with respect to what we would call a class approach.
We think there is no contradiction between the consultation process that's under way on labelling and the amendments to the bill, because CEPA already actually authorizes the use of the imposition of labelling requirements. Indeed, we have already imposed labelling requirements with respect to various substances in various products.
The real issue is, in what circumstances should we require labelling going forward? For what substances in what products can we be more—